Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer

Breast cancer is one of the leading fatal diseases for women worldwide who cannot have surgery typically have to rely on systemic chemotherapy to extend their survival. Doxorubicin (DOX) is one of the most commonly used chemotherapeutic agents against breast cancer, but acquired resistance to DOX ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xiaoxia, Wei, Yingze, Liu, Yushan, Lu, Xiaoyun, Ding, Fei, Wang, Jiatai, Yang, Shuyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434195/
https://www.ncbi.nlm.nih.gov/pubmed/30697969
http://dx.doi.org/10.1002/cam4.1993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434195/
https://www.ncbi.nlm.nih.gov/pubmed/30697969
http://dx.doi.org/10.1002/cam4.1993

Ejemplares similares